Antenatal dexamethasone reduces mortality in preterm infants in low-resource countries
- PMID: 34713493
- DOI: 10.1111/apa.16145
Antenatal dexamethasone reduces mortality in preterm infants in low-resource countries
Comment on
-
Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries.N Engl J Med. 2020 Dec 24;383(26):2514-2525. doi: 10.1056/NEJMoa2022398. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33095526 Free PMC article. Clinical Trial.
References
REFERENCES
-
- Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515-525.
-
- McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12:CD004454.
-
- Althabe F, Belizan JM, McClure EM, et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet. 2015;385(9968):629-639.
-
- Fekih M, Chaieb A, Sboui H, Denguezli W, Hidar S, Khairi H. Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study. Tunis Med. 2002;80(5):260-265.
-
- Qublan HS, Malkawi HY, Hisat MS, et al. The effect of antenatal corticosteroid therapy on pregnancies complicated by premature rupture of membranes. Clin Exp Obstet Gynecol. 2001;28(3):183-186.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources